Oregon Public Employees Retirement Fund Ligand Pharmaceuticals Inc Transaction History

Oregon Public Employees Retirement Fund

$5.08 Billion
Q3 2024

A detailed history of Oregon Public Employees Retirement Fund transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 4,310 shares of LGND stock, worth $455,825. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,310

Previous 4,110 4.87%

Holding current value

$455,825

Previous $346,000 24.57%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$82.7 - $110.11 $16,540 - $22,022	200 Added 4.87%	4,310 $431,000
Q2 2024 Aug 01, 2024	SELL	$68.53 - $87.91 $20,559 - $26,373	-300 Reduced 6.8%	4,110 $346,000
Q1 2024 May 02, 2024	SELL	$68.64 - $89.2 $26,632 - $34,609	-388 Reduced 8.09%	4,410 $322,000
Q4 2023 Feb 12, 2024	SELL	$49.57 - $72.63 $1,487 - $2,178	-30 Reduced 0.62%	4,798 $342,000
Q3 2023 Oct 26, 2023	SELL	$58.86 - $72.67 $17,658 - $21,801	-300 Reduced 5.85%	4,828 $289,000
Q1 2023 May 04, 2023	SELL	$65.67 - $77.08 $13,790 - $16,186	-210 Reduced 3.93%	5,128 $377,000
Q4 2022 Jan 26, 2023	BUY	$61.72 - $96.74 $740 - $1,160	12 Added 0.23%	5,338 $0
Q3 2022 Nov 01, 2022	SELL	$0.01 - $107.56 $2 - $22,480	-209 Reduced 3.78%	5,326 $459,000
Q2 2022 Jul 25, 2022	SELL	$74.52 - $117.06 $54,176 - $85,102	-727 Reduced 11.61%	5,535 $494,000
Q1 2022 Apr 21, 2022	SELL	$94.99 - $151.56 $18,998 - $30,312	-200 Reduced 3.1%	6,262 $704,000
Q4 2021 Feb 01, 2022	SELL	$127.69 - $165.85 $38,307 - $49,755	-300 Reduced 4.44%	6,462 $998,000
Q3 2021 Oct 19, 2021	BUY	$102.33 - $144.73 $112,358 - $158,913	1,098 Added 19.39%	6,762 $942,000
Q2 2021 Jul 23, 2021	BUY	$113.03 - $155.64 $35,265 - $48,559	312 Added 5.83%	5,664 $743,000
Q4 2020 Feb 09, 2021	SELL	$80.55 - $106.05 $20,298 - $26,724	-252 Reduced 4.5%	5,352 $532,000
Q3 2020 Nov 03, 2020	SELL	$89.56 - $126.72 $46,302 - $65,514	-517 Reduced 8.45%	5,604 $534,000
Q2 2020 Jul 21, 2020	SELL	$68.28 - $123.65 $31,203 - $56,508	-457 Reduced 6.95%	6,121 $685,000
Q1 2020 Apr 20, 2020	SELL	$63.37 - $107.88 $84,345 - $143,588	-1,331 Reduced 16.83%	6,578 $478,000
Q4 2019 Feb 05, 2020	SELL	$96.94 - $113.59 $83,950 - $98,368	-866 Reduced 9.87%	7,909 $825,000
Q3 2019 Nov 07, 2019	BUY	$86.25 - $120.16 $13,368 - $18,624	155 Added 1.8%	8,775 $873,000
Q2 2019 Jul 16, 2019	BUY	$107.38 - $129.34 $12,563 - $15,132	117 Added 1.38%	8,620 $984,000
Q1 2019 May 07, 2019	BUY	$105.93 - $142.47 $9,745 - $13,107	92 Added 1.09%	8,503 $1.07 Million
Q4 2018 Feb 07, 2019	SELL	$128.36 - $272.13 $145 Million - $308 Million	-1,132,962 Reduced 99.26%	8,411 $1.14 Million
Q4 2018 Feb 05, 2019	BUY	$128.36 - $272.13 $147 Million - $311 Million	1,141,373 New	1,141,373 $8,000

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.79B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Account

Oregon Public Employees Retirement Fund Ligand Pharmaceuticals Inc Transaction History